Cat.#: ACPP-1236
| Despition | SOX2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1055 | Recombinant Human TIMP1 Protein (Fc Tag) (AC1055) | 50 µg | inquiry |
| ACPP-1218 | Dopamine D2 Receptor Blocking Peptide (AC1218) | 250 µg | inquiry |
| ACPP-1347 | Human HDL Protein (AC1347) | 10 mg | inquiry |
| ACPP-1563 | Human STX4 Protein (AC1563) | 5 µg | inquiry |
| ACPP-1693 | Human CDK1 Protein (AC1693) | 5 µg | inquiry |
| ACPP-1017 | Recombinant Human FGF19 Protein (AC1017) | 50 µg | inquiry |
| ACPP-1567 | Human EFNB2 Protein (AC1567) | 5 µg | inquiry |
| ACPP-1094 | Recombinant Human FGFR4 Protein (Functional) (AC1094) | 10 µg | inquiry |
| ACPP-1554 | Human Human FGF1 (Active) Protein (AC1554) | 500U | inquiry |
| ACPP-1190 | ADCY6 Blocking Peptide (AC1190) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.